drugset / Trial / NCT06451666

Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia

NCT06451666

Phase 3 Unknown 330 enrolled CSPC Ouyi Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

A study to evaluate the efficacy, safety, and pharmacokinetics of pilocarpine HCl ophthalmic solution when administered bilaterally, once daily for 30 days in participants with presbyopia.

Timeline

Start
2024-06-30
Primary completion
2025-11-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pilocarpine Unknown 1.25 % Other

Indications